News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biogen Idec, Inc. (Massachusetts) (BIIB), Roche Holding AG (RHHBF.PK)'s Genentech (RHHBY) End Dispute Over Rituxan Follow-Ons



10/22/2010 6:55:09 AM

Oct 21 (Reuters) - Biogen Idec Inc (BIIB.O) and Roche Holding AG's (ROG.VX) Genentech unit agreed to amend the terms of their collaboration to develop antibody drugs, ending a long-term dispute.

Read at Reuters
Read at Wall Street Journal
Read at Xconomy

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES